Navigation Links
Neurologist Advises: Botox for Chronic Migraines Provides Relief to Those Suffering
Date:7/16/2014

(PRWEB) July 16, 2014

For adults with Chronic Migraines, clinically indicated as 15 or more headache days a month, each lasting 4 hours or more, BOTOX® is the first and only FDA-approved preventive treatment proven to reduce headache days every month. BOTOX® can prevent up to nine headache days a month. Brody Henkel, M.D. of Neurological Specialties of Tampa is now speaking about the administration of Botox within his practice to help those suffering from this chronic condition and want to shed light on this new prevention therapy.

Not knowing when a headache or migraine will occur can be challenging. While other treatments may help you once you already have a headache, a preventive medication like BOTOX® therapy is approved to help prevent headache days.

BOTOX® (onabotulinumtoxinA) is a prescription medicine that is injected to prevent headaches in adults with chronic migraines, according to Allergan, the manufacturer of BOTOX®. There are many ways to manage Chronic Migraines; most medications are either acute or preventive.

Headache Specialists often prescribe preventive medications for Chronic Migraine patients; however, a treatment plan may include acute and preventive treatment, so it's important to understand how they work to manage Chronic Migraines.

Henkel provides insight that patients should discuss with their doctor whether it is appropriate for them to include BOTOX® as a preventative treatment. Appropriate questions to consider should include:

1. On average, how many days each month do you experience headaches?
2. On average, how many days per month are you headache-free?
3. Do you have headaches that last 4 hours or more?
4. Do you experience nausea, vomiting, sensitivity to light or sound with your headaches?
5. How much of an effect do headaches and/or migraines have on your daily life?

“It may take several weeks for a patient to experience a response to the treatment,” says Henkel. “Patients typically experience an initial response by the time we check in for their four-week evaluation and then at 24 weeks, the treatment has proven to prevent chronic migraines.”

BOTOX® therapy is injected every 12 weeks.

Henkel also explains, “A total of 31 injections are made to seven key areas of the head and neck. We use very fine needles, so that the injections feel like tiny pinpricks. Some patients experience temporary mild discomfort, but overall the treatment is fairly manageable for our patients.”

About Neurological Specialties: Founded in 1980, Neurological Specialties is the only medical group in the Tampa Bay area with both neurologists and neurosurgeons together in the same practice. The office is located at 2816 West Virginia Avenue, in Tampa, Florida. For more information, visit http://www.neurologicalspecialties.com.

About Dr. Henkel:

A Florida native, Dr. Brody L. Henkel graduated from the University of Florida, earned his medical degree at St. George’s University, and completed his Neurology Residency and Fellowship in Clinical Neurophysiology at the Medical University of South Carolina in Charleston. Dr. Henkel is a Diplomate of the American Board of Psychiatry and Neurology, and is board eligible in Electrodiagnostic Medicine. He has a special interest in the delivery of EMG/NCS and EEG studies, which are available in the office on a full-time basis.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12023430.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Loyola neurologist is co-editor of 3-volume, 1,480-page guide to clinical neurology
2. Microbleeds important to consider in brain-related treatments, UCI neurologist says
3. UNC child neurologist finds potential route to better treatments for Fragile X, autism
4. Neurologist Dr. Marisa C. Chang of Neurological Associates of West Los Angeles Has Been Named a Southern California Rising Star by Super Doctors®
5. Neurologists report unique form of musical hallucinations
6. Many neurologists unaware of safety risks related to anti-epilepsy drugs
7. Alzheimers Patients May Face Looming Shortage of Neurologists
8. The doctor wont see you now? Study: US facing a neurologist shortage
9. Hospital-based neurologists worry about career burnout
10. 2 books by Loyola neurologist Highly Commended by British Medical Association
11. Decrease Fine Lines and Wrinkles with Face Whisperer® Day Cream with Argireline®, Known as the Natural Botox; On Sale Now at Sublime Beauty®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: